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Following the European Union (EU) Council 
Recommendation on prudent use of antimicrobial 
agents in human medicine in 2001, and the success 
of national campaigns, i.e. Belgium and France, the 
European Centre for Disease Prevention and Control 
(ECDC) decided to establish the European Antibiotic 
Awareness Day (EAAD) on 18 November as platform 
to support national campaigns across Europe. This 
article provides an overview of EAAD tools, materials, 
and activities developed during the first five years. 
It shows that EAAD has been successful due to good 
cooperation between ECDC and national institutions, 
strong political and stakeholder support and evidence-
based development of campaign materials. EAAD has 
provided a platform for pre-existing national cam-
paigns and encouraged similar campaigns to develop 
where neither political support had been secured, 
nor financial support had been available. As a result, 
participating countries have continuously expressed 
strong support for ECDC to continue its work on EAAD. 
This has been endorsed by a steadily increasing num-
ber of countries participating and the growing interest 
of varied professional and stakeholder organisations. 
We conclude that EAAD should continue to act as cata-
lyst for discussion and as mechanism to raise aware-
ness of the public and prescribers about prudent use 
of antibiotics. 
Introduction
The emergence and spread of antibiotic resistance, is 
recognised as a global problem. Its immediate conse-
quence is that, only a limited number of antibiotics, 
and sometimes even no antibiotic, is available for the 
treatment of infections caused by resistant bacteria. 
Other direct consequences for patients include delayed 
administration of appropriate antibiotic therapy, longer 
stays in hospitals, higher healthcare costs and poor 
patient outcomes [1]. Worldwide action is thus neces-
sary to avert an impending threat to human health [2].
Of the steps that need to be taken to address antibiotic 
resistance, we believe that improving antibiotic use is 
the most important action needed to greatly slow the 
development and spread of antibiotic-resistant bac-
teria. Antibiotics are frequently used inappropriately 
or when they are not needed, in both humans and 
animals.
Following adoption of the European Union (EU) Council 
Recommendation on the prudent use of antimicrobial 
agents in human medicine in November 2001, which 
stated that EU Member States should inform the gen-
eral public of the importance of prudent use of anti-
microbial agents and the success of some national 
campaigns, such as Belgium and France, the European 
Centre for Disease Prevention and Control (ECDC) 
decided in 2008 to establish the European Antibiotic 
Awareness Day (EAAD) on 18 November as a platform 
for providing support to national campaigns across the 
region [3].
Since 2008, numerous health-related and professional 
organisations, as well as the European Commission 
and the World Health Organization Regional Office 
for Europe (WHO/Europe), have partnered with ECDC 
in preparing communications materials and planning 
activities targeting both communities and hospitals 
for EAAD. In 2012, under the banner of EAAD, national 
campaigns to inform about prudent antibiotic use took 
place in 43 European countries, with the target audi-
ences selected by campaign organisers at national 
level, including both general public and prescribers.
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This perspective describes the development of materi-
als and tools during the past five years, and provides 
a review of the activities and achievements of EAAD. 
It also presents results from the annual questionnaire 
provided by participating countries and from an inde-
pendent monitoring of the media coverage. 
Development of materials and tools for the 
campaigns
ECDC endeavoured throughout the year 2008 to provide 
participating countries with a core set of tools, includ-
ing a common name ‘European Antibiotic Awareness 
Day’ and logo, key messages, a dedicated website and 
communications materials targeting parents and carers 
of young children [4,5]. The various steps in prepara-
tion for the first EAAD that took place on 18 November 
2008 were previously published [6].
In the following years, EAAD has focussed on pri-
mary care prescribers (2009) and hospital prescribers 
(2010). In each case, campaign messages and materials 
were developed following evidence-based processes, 
i.e. results of systematic reviews and subsequently 
they were reviewed by the EAAD Technical Advisory 
Committee and tested in focus groups representing the 
target audience in question. The campaign materials 
included a dedicated EAAD website, logos and visuals 
i.e., hedgehog mascot and TV and web spots, adver-
torials and on line banners, factsheets and prescrib-
ing check lists, patient brochures, template letters 
and presentations. All campaign materials were made 
available on the EAAD website [7].
In 2011 and 2012, the focus of EAAD shifted to con-
solidation, with new activities to support the national 
campaigns at a process level as opposed to the devel-
opment of new content [8,9]. Given the global financial 
crisis and competing priorities, a number of countries 
reviewed government support for the annual cam-
paigns. ECDC chose to strengthen its support to the 
participating countries by providing strategies and 
tools to support the delivery of the existing key mes-
sages and materials including a social media toolkit, 
and to foster impact evaluation strategies, and a pilot 
training course on development, implementation and 
evaluation of prudent antibiotic use campaigns.
Each year, participating countries answered a ques-
tionnaire providing feedback to ECDC on their national 
activities for EAAD. The scope of this questionnaire is to 
gather information about the national campaigns: e.g. 
type and number of the activities, chosen target audi-
ence governmental support and EAAD material used 
to support those activities. In addition since 2010, an 
independent monitoring of the media coverage of EAAD 
in terms of print, online and social media is performed.
Coverage of the campaigns
Since 2008, the number of European countries partici-
pating in the EAAD has increased year on year. In 2008, 
all EU Member States plus Norway, Iceland, Croatia, 
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the Former Yugoslav Republic of Macedonia and Turkey 
participated making a total of 32 countries. Between 
2009 and 2012, this number increased to 43 coun-
tries, firstly with the addition of other EU enlargement 
countries: Albania, Bosnia and Herzegovina, Kosovo*, 
Montenegro and Serbia [10,11]. In 2012, through 
cooperation with WHO/Europe, Armenia, Azerbaijan, 
Belarus, Kyrgyzstan, Moldavia and Tajikistan also par-
ticipated (Figure).
 
Thirty-two countries initially participated to EAAD 
in 2008; one additional country in 2009, two addi-
tional countries in 2010; in 2011 two further countries 
joined and six more in 2012. Thus in 2012, a total of 43 
European countries participated and in 2013, the num-
ber countries reached 45 (unpublished data).
Each participating country has carried out at least one 
activity targeting the general public, primary care pre-
scribers or hospital prescribers (Table 1). The target 
audiences have predominantly followed the theme set 
by ECDC at European level, i.e. twenty-seven of 33 par-
ticipating countries targeted primary care prescribers 
in 2009 and 31 of 35 countries targeted hospital pre-
scribers in 2010 [12]. In the subsequent years of con-
solidation, ECDC has seen a continued focus on all 
three target audiences with in 2012, 36 of 43 countries 
organising activities targeted at the general public, 34 
at primary care prescribers and 30 at hospital prescrib-
ers (Table 1).
Governmental support
Government support has been an essential element in 
funding and endorsing national campaigns. This sup-
port was universal in 2008, but then probably due to 
financial constraints and/or competing priorities (e.g. 
the 2009 influenza A(H1N1)pdm pandemic), a number of 
countries were not able to secure on-going government 
support for the annual campaigns. In 2009, 23 coun-
tries had government support, of which 14 were able to 
secure funding for their national campaigns as part of 
this support. The level of government funding further 
decreased and in 2010 only nine countries remained 
with government funding. This number increased again 
by 2012, with 30 countries then receiving support, of 
which 15 received financial support, from their govern-
ments (Table 2).
As government support varied in 2009 and 2010, cam-
paign planners considered a broader scope of alterna-
tive groups to provide support and funding, such as 
professional groups and non-governmental organisa-
tions. By 2010, 16 countries reported cooperation with 
professional groups, such as medical associations and 
professional healthcare organisations. In 2011 and 
2012, this number increased to 27 and 35 countries, 
respectively, of which 10 countries and 19 countries, 
respectively, reported receiving sponsorships (Table 2).
Print, online and social media coverage
ECDC has consistently monitored print and online press 
coverage of EAAD in all 24 official EU languages since 
2010. In 2010 and in 2011, 476 and 611 articles related 
to EAAD were published, respectively, during a four-
month period between 15 October and 15 February. In 
2012, 446 articles related to EAAD were published in 
47 countries worldwide during a two-month monitor-
ing period between 18 October and 28 December. This 
coverage represented a range of 42 to 72 million vis-
its of news online and a print reach of 18 to 77 million 
persons.
The EAAD website (http://ecdc.europa.eu/en/EAAD/
Pages/Home.aspx) includes communications materials 
in all EU languages [7]. Analysis of the EAAD website 
showed around a 200% increase in web traffic i.e., 
during the week of 18 November each year compared 
to the previous one. The most visited EAAD pages 
were the country activities, toolkits, multimedia news 
release (for English version), as well as the factsheets 
and national campaigns (for the multilingual websites).
Since 2011, ECDC has increasingly used social media 
(e.g. Twitter, Facebook) to convey EAAD messages. In 
2012, EAAD was mentioned in 1,773 tweets, with over 
of 3.7 million impressions reached. In 2012, ECDC with 
WHO/Europe and the European Commission held a 
joint Twitter chat on 20 November reaching 2.5 million 
impressions (out of the 3.7 million stated above). EAAD 
was also mentioned 58-times in the monitored period 
in blogs, e.g. European Medical Students’ Association. 
The postings focused on the EAAD and the use of 
antibiotics.
From 2009 to 2012, ECDC broadcasted a TV spot rais-
ing awareness on antimicrobial resistance and EAAD 
on a pan-European TV channel (Euronews), reaching an 
average of 14 million EU citizens each year and among 
them an average of 1.5 million people working in the 
healthcare and medicine sector in Europe.
Discussion
In 2007, when the idea of a European-level initiative to 
raise awareness about the importance of prudent use 
of antibiotics was agreed, ECDC hosted two meetings 
of national antimicrobial resistance (AMR) focal points, 
nominated by the Member States. In these meetings in 
September 2007 and March 2008, the form that the ini-
tiative should take and the benefits that it could bring 
were discussed as well as draft campaign materials, 
and feedback was given. In the end, the initiative was 
conceived as a day (EAAD) upon which national cam-
paigns could be launched and where the power of many 
could amount to more than the power of one [6,13–16]. 
Our analysis after five editions of EAAD, shows that it 
obviously responded to a need at European level.
The EAAD has provided a platform for pre-existing 
national campaigns and encouraged similar campaigns 
to develop in other countries where neither political 
support had been secured, nor financial support been 
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Austria • • • • • • • • • • • • • • • • • • • • • •
Belgium • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Bulgaria • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Croatia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Cyprus • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
Czech Republic • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Denmark • • • • • • • • • • • • • • • • • • • •
Estonia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Finland • • • • • • • • •
France • • • • • • • • • • • • • • • • • • • • • • • • 
Germany • • • • • • • • • • • • • • • • • • • • •
Greece • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Hungary • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Ireland • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Italy • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Latvia • • • • • • • • • • • • • • • • • • • • •
Lithuania • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Luxembourg • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Malta • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Netherlands • • • • • • • • • • • • • • • • • • • • • • • •
Poland • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Portugal • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Romania • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Slovakia • • • • • • • • • • • • • • • • • • • • • • • • • • •
Slovenia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Spain • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Sweden • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
United Kingdom • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
European Economic Area
Iceland • • • • • • • • • • • • • • • • • • •
Norway • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Other countries
Albania • • • • • • • • • • • • • • • • • • • • • • • •
Bosnia and Herzegovina • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Former Yugoslav Republic 
of Macedonia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Kosovo* • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Montenegro • • • • • • • • •
Serbia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Turkey • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Each dot corresponds to one activity-year.
* This designation is without prejudice to positions on status, and is in line with United Nations Security Council Resolution 1244/99 and the  
International Court of Justice Opinion on the Kosovo declaration of independence. 
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Austria • • • • • • • • • • • • • • • • • • • • • •
Belgium • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Bulgaria • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Croatia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Cyprus • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
Czech Republic • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Denmark • • • • • • • • • • • • • • • • • • • •
Estonia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Finland • • • • • • • • •
France • • • • • • • • • • • • • • • • • • • • • • • • 
Germany • • • • • • • • • • • • • • • • • • • • •
Greece • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Hungary • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Ireland • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Italy • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Latvia • • • • • • • • • • • • • • • • • • • • •
Lithuania • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Luxembourg • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Malta • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Netherlands • • • • • • • • • • • • • • • • • • • • • • • •
Poland • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Portugal • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Romania • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Slovakia • • • • • • • • • • • • • • • • • • • • • • • • • • •
Slovenia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Spain • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Sweden • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
United Kingdom • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
European Economic Area
Iceland • • • • • • • • • • • • • • • • • • •
Norway • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Other countries
Albania • • • • • • • • • • • • • • • • • • • • • • • •
Bosnia and Herzegovina • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Former Yugoslav Republic 
of Macedonia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Kosovo* • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Montenegro • • • • • • • • •
Serbia • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Turkey • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Each dot corresponds to one activity-year.
* This designation is without prejudice to positions on status, and is in line with United Nations Security Council Resolution 1244/99 and the  




































































































































Austria • • • • • • • • • • • • • • • • • • •
Belgium • • • • • • • • • • • • • • • • • • • • • • • • • •
Bulgaria • • • • • • • • • • • • • •
Croatia • • • • • • • • • • • • • • • • • • • • • • • • •
Cyprus • • • • • • • • • • • • • •
Czech Republic • • • • • • • • • • • • • • • • • • • • •
Denmark • • • • • • • • •
Estonia • • • • •
Finland • • • •
France • • • • • • • • • • • • • • •
Germany • • • • • • • • • • • • •
Greece • • • • • • • • • • •
Hungary • • • • • • •
Ireland • • • • • • • • • • • • • • • • • •
Italy • • • • • • • • • • • • • •
Latvia • • • • • • • •
Lithuania • • • • • • • • • • • • • • • •
Luxembourg • • • • • • • • • • • • • • •
Malta • • • • • • • • • • • •
Netherlands • • • • • • • • • • • • •
Poland • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Portugal • • • • • • • • • • • • • •
Romania • • • • • • • • • • • • • • • • • •
Slovakia • • • • • • • • • • • • • • •
Slovenia • • • • • • • • • • • • • • • • •
Spain • • • • • • • • • • • • • • • •
Sweden • • • • • • • • • • • • • •
United Kingdom • • • • • • • • • • • • • • • • • • • • • • • • • •
European Economic Area
Iceland • • • • • •
Norway • • • • • • • • • • • •
Other countries
Albania • • • • • • • • •
Bosnia and Herzegovina • • • • • • •
Former Yugoslav Republic 
of Macedonia • • • • • • • • • • • • • • • • • • • • • • • • • •
Kosovo* • • • • • • • • • • • •
Montenegro • • • • • • • •
Serbia • • • • • • • •
Turkey • • • • • • • • • • • • • • • • • • • • • •
Each dot corresponds to one activity-year.
* This designation is without prejudice to positions on status, and is in line with United Nations Security Council Resolution 1244/99 and the 
International Court of Justice Opinion on the Kosovo declaration of independence. 
Table 2
Overview of government and stakeholders’ support received per country, European Antibiotic Awareness Day campaigns, 
2008–2012
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available. As a result, year on year, in their reply to 
the annual questionnaire, countries have expressed 
their strong support for ECDC to continue its work on 
the EAAD. This has also been highlighted by a stead-
ily increasing number of countries participating and 
the growing interest of varied professional and stake-
holder organisations.
Evaluation of EAAD in terms of understanding its 
impact on antibiotic consumption and on antibiotic 
resistance is difficult because (i) the effects will vary 
depending on the country as a result of variations in 
the extent and the intensity of the national campaign 
in each country and (ii) these effects are unlikely to be 
immediate as shown from previous national campaigns 
in some Member States. In addition, it is important to 
remember that since the campaigns have been applied 
heterogeneously at national levels, according to local 
needs and resources, a one size fits all impact analysis 
evaluation is not appropriate.
Regular opinion polls, i.e. ‘Special Eurobarometers’ 
on antimicrobial resistance commissioned by the 
European Commission, however, should help identify 
improvements in the knowledge, perception and self-
reported attitudes of Europeans with antibiotics [17,18]. 
Additionally, the effects on antibiotic consumption 
and on antibiotic resistance in the European countries 
most active in the campaigns should become visible 
in the data reported to the European Surveillance of 
Antimicrobial Consumption Network (ESAC-Net) and 
the European Antimicrobial Resistance Surveillance 
Network (EARS-Net), respectively [19–21]. By providing 
training support on the development, implementation 
and evaluation of prudent antibiotic use campaigns, 
ECDC hopes that common evaluation indicators can 
now be developed at European level and implemented 
as part of national campaigns from 2014 onwards.
In 2013, ECDC and its partners launched the 6th edi-
tion of EAAD on 15 November 2013, with the emphasis 
that ‘Everyone is responsible’ for addressing antibiotic 
resistance and for using antibiotics more prudently, 
during a European Commission press conference [22]. 
During this press conference, the results of a recent 
‘Special Eurobarometer’ on the attitudes and knowl-
edge of Europeans about antibiotics, were presented 
together with a review of new research initiatives 
related to antimicrobial resistance and the latest sur-
veillance data on resistance trends [21,23]. In par-
ticular, the ‘Special Eurobarometer’ on antimicrobial 
resistance showed a 5% decrease between 2009 and 
2013, in the percentage of Europeans who took anti-
biotics during the past year and an increasing aware-
ness of Europeans that antibiotics do not kill viruses 
[18]. These are positive developments that may reflect 
the continuous efforts made by Member States in the 
framework of EAAD. This is also the rationale for an 
annual EAAD to support to national campaigns.
 
In 2013, ECDC arranged for a first extended global 
Twitter conversation with its partners in the United 
States (US), Canada and Australia, and in connec-
tion with an EAAD Twitter chat organised jointly with 
the European Commission and WHO/Europe using the 
hashtag #EAAD. Dedicated EAAD Twitter (@EAAD_EU) 
and Facebook (http://facebook.com/eaad.eu) accounts 
have been set up for the first time. The full evalua-
tion of the 2013 edition of EAAD is currently ongoing. 
In reply to the annual questionnaire sent by ECDC to 
evaluate the activities in 2013, 22 of 41 responding 
countries highlighted that there was a change in their 
country that could be attributed to the momentum cre-
ated by EAAD.
Looking to the future, self-medication with antibiot-
ics has been identified as a new focus for EAAD 2014. 
Concerns about antimicrobial resistance and the need 
for a more prudent use of antibiotics are of global 
significance and are progressively being raised on 
political agendas. A growing number of countries and 
regions across globe, including the US, Canada and 
Australia, have aligned the timing of their activities to 
that of EAAD and the week of 18 November is increas-
ingly being recognised as the moment to raise aware-
ness about prudent use of antibiotics. This is a strong 
encouragement for the coordinators of the EAAD to 
continue acting as a global catalyst for discussion and 
raising awareness about prudent use of antibiotics. 
Members of the European Antibiotic Awareness Day 
Technical Advisory Committee (i.e., experts and stake-
holders who provided technical advice to ECDC as part 
of the Technical Advisory Committee during 2007-2012):
R. Muchl (Austria)a, J. Eyckmans (Belgium), J. Šturmaa (Czech 
Republic), H. Žemličkováa (Czech Republic), V Jindráka (Czech 
Republic); E. Parviainen (Finland), B. Schlemmera (France), 
A. Lepape (France), M. Valtier (France), H. Giamarelloua 
(Greece), A. Antoniadoua (Greece), G. Daikos (Greece), M. 
Mellesa (Hungary), M. Grazia Pompa (Italy); P. Casolari 
(Italy), S. Caplinskas (Lithuania), M. Borga (Malta), I.C. 
Gyssensa (The Netherlands), T. Verheij (The Netherlands), 
H.P. Muñiza (Norway), H. Nøklebya (Norway), W. Hryniewicza 
(Poland), M. Szjakowska (Poland), P. Ribeiro Da Silva 
(Portugal), S. Kovacsova (Slovakia), M. Vrdeljaa (Slovenia), 
J. Camposa (Spain), C. Llor (Spain), O. Carsa (Sweden), A.-L. 
How (Sweden), A. Sten (Sweden), K. Wahlberga (Sweden), E. 
Gilgunn-Jones (United Kingdom), D. Lecky (United Kingdom & 
e-Bug), C. McNultya (United Kingdom & e-Bug), C. Butler (UK), 
N. Heine/N. Safrany/A. Walters/V. Houdry/B. Toussaint/A. 
Gijsens/M. Kokki (DG SANCO, European Commission), A. 
Van Hengel/J. Bunikis/A. Lönnroth Sjödén (DG RESEARCH, 
European Commission), D. Lo Fo Wong/K. de Joncheere/H. 
Kruse/V. Hafner/ B. Ganter/A.P. Coutinho/R. Andraghetti/O. 
Polishchuk/H. Kluge/N. Emiroglu/H. Bak Pedersen (WHO/
Europe), R. Norrby (ESCMID), B. Beger/L. Tiddens-Engwirda 
(CPME), J. Chave (PGEU), G.Ferreira (EPSA).
Members of the European Antibiotic Awareness Day 
Collaborative Group who contributed at least one year 
during 2008-2012:
Austria: R. Strauss, P. Apfalter, S. Metz-Gercek, H. 
Mittermayerb; Belgium: S. Coenen; Bulgaria: T. Kantardjiev, 
T. Velinov, B. Todorova; Croatia: A. Tambić Andrašević; 
Cyprus: N. Paphitou, C. Hadjianastasiou, M. Alexandrou, D. 
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Pieridou-Bagatzouni; Denmark: A.M. Hammerum, R. Skov, K. 
Fuursted, G. Strøbæk, N. Frimodt-Møller; Estonia: K. Kutsar, 
M. Muzotsin; Finland: J. Jalava, A. Hakanen, M. Gunell, O. 
Lyytikäinen, J.Vuopio, P. Huovinen; France: J.-M. Azanowsky; 
Germany: A. Ziegelmann, K. de With; Hungary: K. Böröcz, A. 
Kurcz, I. Luif, E. Szilágyi;
Iceland: T. R. Thorsteinsdottir, T. Gudnason, G. 
Sigmundsdottir, J. Hedinsdottir, K. Kristinsson, H. Briem; 
Ireland: R. Cunney; Italy: A. Pantosti, P. Salcuni; Latvia: U. 
Dumpis, S. Terela; Lithuania: A. Sinkeviciute, R. Valinteliene; 
Luxembourg: S. Christmann, E. Heisbourg;
Malta: P. Zarb; The Netherlands: S. de Greeff, J. Prins, L. 
Wijgergangs; Norway: M. Steinbakk, G. Wøien, M. Lindbæk, 
G.S. Simonsen; Poland: B. Mazinska, A. Olczak Pieńkowska; 
Portugal: J.A. Paiva, A.C. Costa, J. Melo Cristino; Romania: 
I. Codita, A. Băicuş, A. Canton; Slovakia: L. Siegfried, H. 
Hupková; Slovenia: M. Čižman, A. Svetlin, S. Rojs; J. Kolman; 
Spain: J. Oteo; B. Aracil; M. Pérez-Vázquez; Sweden: I. 
Riesenfeld-Örn, J. Struwes, A. Tegnell; United Kingdom: 
S. Wellsteed, M. Robinson, L. Willock; D. Ashiru-Oredope; 
Montenegro: G. Mijović; The Former Yugoslav Republic 
of Macedonia: G. Bosevska; Serbia: Z. Jelesić; Turkey: N. 
Çöplü; H. Şimşek; Albania: P. Pipero, A. Ylli; Bosnia and 
Herzegovina: M. Hukić; Kosovo*: L. Raka.
a Members of both the European Antibiotic Awareness Day 
Technical Advisory Committee and of the European Antibiotic 
Awareness Day Collaborative Group.
b Deceased.
* This designation is without prejudice to positions on status, 
and is in line with United Nations Security Council Resolution 
1244/99 and the International Court of Justice Opinion on the 
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